Kothary, V., Scherl, E. J., Bosworth, B., Jiang, Z., DuPont, H. L., Harel, J., . . . Dogan, B. (2013). Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg-β-Naphthylamide-Inhibitable Efflux Pumps. American Society for Microbiology.

Kothary, Vishesh, Ellen J. Scherl, Brian Bosworth, Zhi-Dong Jiang, Herbert L. DuPont, Josee Harel, Kenneth W. Simpson, và Belgin Dogan. Rifaximin Resistance in Escherichia Coli Associated With Inflammatory Bowel Disease Correlates With Prior Rifaximin Use, Mutations in RpoB, and Activity of Phe-Arg-β-Naphthylamide-Inhibitable Efflux Pumps. American Society for Microbiology, 2013.

Kothary, Vishesh, et al. Rifaximin Resistance in Escherichia Coli Associated With Inflammatory Bowel Disease Correlates With Prior Rifaximin Use, Mutations in RpoB, and Activity of Phe-Arg-β-Naphthylamide-Inhibitable Efflux Pumps. American Society for Microbiology, 2013.